Cargando…

Sclerosing epithelioid fibrosarcoma: rare and serious

Sclerosing Epithelioid Fibrosarcoma (SEF) is a rare form of soft tissue sarcoma. It is characterized by a slow evolution, with local recurrences and late metastases that are mainly pulmonary and pleural in about 50% of cases. The treatment is based on the surgery which must be as wide as possible. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahyaoui, Mounir, Benhammou, Mohammed, Aharram, Soufiane, Amghar, Jawad, Sadougui, Mohammed, Agoumi, Omar, Daoudi, Abdelkrim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422754/
https://www.ncbi.nlm.nih.gov/pubmed/32849986
http://dx.doi.org/10.11604/pamj.2020.36.131.18668
_version_ 1783570061981646848
author Yahyaoui, Mounir
Benhammou, Mohammed
Aharram, Soufiane
Amghar, Jawad
Sadougui, Mohammed
Agoumi, Omar
Daoudi, Abdelkrim
author_facet Yahyaoui, Mounir
Benhammou, Mohammed
Aharram, Soufiane
Amghar, Jawad
Sadougui, Mohammed
Agoumi, Omar
Daoudi, Abdelkrim
author_sort Yahyaoui, Mounir
collection PubMed
description Sclerosing Epithelioid Fibrosarcoma (SEF) is a rare form of soft tissue sarcoma. It is characterized by a slow evolution, with local recurrences and late metastases that are mainly pulmonary and pleural in about 50% of cases. The treatment is based on the surgery which must be as wide as possible. The efficacy of adjuvant therapy in the control of SEF is not yet demonstrated. Chemotherapy is used in recurrences, some have also proposed radiotherapy. Long-term follow-up of patients with SEF is therefore essential.
format Online
Article
Text
id pubmed-7422754
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-74227542020-08-25 Sclerosing epithelioid fibrosarcoma: rare and serious Yahyaoui, Mounir Benhammou, Mohammed Aharram, Soufiane Amghar, Jawad Sadougui, Mohammed Agoumi, Omar Daoudi, Abdelkrim Pan Afr Med J Case Report Sclerosing Epithelioid Fibrosarcoma (SEF) is a rare form of soft tissue sarcoma. It is characterized by a slow evolution, with local recurrences and late metastases that are mainly pulmonary and pleural in about 50% of cases. The treatment is based on the surgery which must be as wide as possible. The efficacy of adjuvant therapy in the control of SEF is not yet demonstrated. Chemotherapy is used in recurrences, some have also proposed radiotherapy. Long-term follow-up of patients with SEF is therefore essential. The African Field Epidemiology Network 2020-06-25 /pmc/articles/PMC7422754/ /pubmed/32849986 http://dx.doi.org/10.11604/pamj.2020.36.131.18668 Text en Copyright: Mounir Yahyaoui et al. https://creativecommons.org/licenses/by/4.0 The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yahyaoui, Mounir
Benhammou, Mohammed
Aharram, Soufiane
Amghar, Jawad
Sadougui, Mohammed
Agoumi, Omar
Daoudi, Abdelkrim
Sclerosing epithelioid fibrosarcoma: rare and serious
title Sclerosing epithelioid fibrosarcoma: rare and serious
title_full Sclerosing epithelioid fibrosarcoma: rare and serious
title_fullStr Sclerosing epithelioid fibrosarcoma: rare and serious
title_full_unstemmed Sclerosing epithelioid fibrosarcoma: rare and serious
title_short Sclerosing epithelioid fibrosarcoma: rare and serious
title_sort sclerosing epithelioid fibrosarcoma: rare and serious
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422754/
https://www.ncbi.nlm.nih.gov/pubmed/32849986
http://dx.doi.org/10.11604/pamj.2020.36.131.18668
work_keys_str_mv AT yahyaouimounir sclerosingepithelioidfibrosarcomarareandserious
AT benhammoumohammed sclerosingepithelioidfibrosarcomarareandserious
AT aharramsoufiane sclerosingepithelioidfibrosarcomarareandserious
AT amgharjawad sclerosingepithelioidfibrosarcomarareandserious
AT sadouguimohammed sclerosingepithelioidfibrosarcomarareandserious
AT agoumiomar sclerosingepithelioidfibrosarcomarareandserious
AT daoudiabdelkrim sclerosingepithelioidfibrosarcomarareandserious